Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2017-001068-39-ES
EUCTR2017-001068-39-ES
Active, not recruiting
Phase 1

Changes in the bone morphology of the post-extraction socket, preserved with platelet-rich fibrin and leukocytes (L-PRF) versus Conventional treatment

OMEQUI0 sites40 target enrollmentAugust 8, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsRegenerative potential of L-PRFTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Dentistry [E06]
DrugsL-PRF (INTRASPIN SYSTEM )GEISTLICH BIO-OSS® COLLAGEN

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Regenerative potential of L-PRF
Sponsor
OMEQUI
Enrollment
40
Status
Active, not recruiting
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 8, 2017
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
OMEQUI

Eligibility Criteria

Inclusion Criteria

  • •Patients older than 18 years Presence of oral health with plaque index and bleeding
  • •not exceeding 25%. Need to perform dental extraction in anterosuperior zone
  • •involving teeth in position 15 \- 25 (both included) Presence of more than 60% of the
  • •bone at the radiographic level
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 40
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Smokers of more than 20 cigarettes Presence of medical pathology that prevents
  • •the application of the treatments, has an impact on the response of these and the
  • •healing process: protein and vitamin deficiency, therapeutic radiation, metabolic
  • •disorders (diabetes, hypercalcemia ...), drug disorders (antimetabolic,
  • •immunosuppressive) And hormonal, allergy to some component of the treatments
  • •applied in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Dental and Skeletal Changes Following Bone- and Tooth-borne Maxillary Protraction with Miniscrews and Class III ElasticsSkeletal Class III malocclusionOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
ACTRN12623000189628Professor Marie Cornelis30
Recruiting
Not Applicable
Changes in bone and surrounding soft tissue structure, metabolism, and vascularisation in Patient with periprosthetic joint infection of the knee and hipT84.5Infection and inflammatory reaction due to internal joint prosthesis
DRKS00022515Charité Campus Mitte60
Recruiting
Phase 1
To determine the changes in thickness of bone before and after bone cutting procedure(corticotomy) which is done to reduce treatment time in patients undergoing orthodontic treatment.Health Condition 1: null- systemically healthy and orally indicated for orthodontic treatment (Bimaxillary Class II Malocclusion Cases)
CTRI/2017/10/010263I
Active, not recruiting
Phase 1
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody.An investigator-led, industry supported, multicentre, open-label, single treatment arm, prospective clinical trial. - Effects of B cell depletion on bone turnover in rheumatoid arthritis.
EUCTR2010-020499-50-GBSouth Tees Hospitals NHS Foundation Trust46
Completed
Not Applicable
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting antibody
ISRCTN82317088South Tees Hospitals NHS Foundation Trust (UK)46